Show simple item record

dc.contributor.authorHiggs, Peter
dc.contributor.authorSacks-Davis, R.
dc.contributor.authorGold, J.
dc.contributor.authorHellard, M.
dc.date.accessioned2017-07-27T05:20:56Z
dc.date.available2017-07-27T05:20:56Z
dc.date.created2017-07-26T11:11:11Z
dc.date.issued2011
dc.identifier.citationHiggs, P. and Sacks-Davis, R. and Gold, J. and Hellard, M. 2011. Barriers to receiving hepatitis c treatment for people who inject drugs myths and evidence. Hepatitis Monthly. 11 (7): pp. 513-518.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/54407
dc.description.abstract

Background: Alcohol consumption, current injecting drug use, and pre-existing mental illness have been identified as 3 of the main reasons for excluding patients from treatment for hepatitis C. Objectives: We reviewed the literature to obtain an evidence base for these common exclusion criteria. Materials and Methods: We reviewed original research and meta-analyses investigating the effects of alcohol consumption, current injecting drug use, and pre-existing mental illness. Results: We identified 66 study reports relevant to the review, but found only limited evidence to support withholding of treatment on the basis of the 3 previously mentioned exclusion criteria. Conclusions: Currently, there is a lack of evidence for many of the barriers faced by patients in availing treatment for hepatitis C. Adherence to treatment routine was found to be a better predictor of sustained virological response than injecting drug or alcohol consumption during treatment period or the presence of a pre-existing mental disorder. Although several challenges remain, we need to ensure that treatment decisions are based on the best available evidence and the treatment is performed appropriately on a case-by-case basis. © 2011 Kowsar M.P.Co. All rights reserved.

dc.publisherTehran Hepatitis Center
dc.titleBarriers to receiving hepatitis c treatment for people who inject drugs myths and evidence
dc.typeJournal Article
dcterms.source.volume11
dcterms.source.number7
dcterms.source.startPage513
dcterms.source.endPage518
dcterms.source.issn1735-143X
dcterms.source.titleHepatitis Monthly
curtin.departmentNational Drug Research Institute (NDRI)
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record